IP Library › Granted Patent US 8,361,055
Granted Patent B2
US 8,361,055 · App. 12/626,393 · Granted Jan 29, 2013

Syringe and method for reconstitution of dry-form drugs and medicines

Inventor: Peter L. Tucker (Charlotte, NC)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,361,055
App. No.
12/626,393
Granted
Jan 29, 2013
Kind
B2
Abstract

A method of reconstituting and administering an injectable fluid distributed to practitioners in dry-form includes receiving a drug or medicine in dry form, selecting a reconstitution concentration for the drug or medicine, reconstituting a desired number of units of the drug or medicine by adding diluent to the dry-form drug or medicine, selecting a syringe having units marked according to the selected reconstitution concentration, drawing up a desired number of drug or medicine units using the selected syringe, and administering a desired number of units according to the unit markings on the selected syringe. Such a syringe includes a barrel, a plunger assembly that has a plunger handle and a piston, a needle, and a needle cap. The syringe includes a visual indicia, representing a first drug concentration contained in the barrel, that is distinguishable from a corresponding visual indicia, on a second syringe, representing a second drug concentration.

Claims (26)

1. A method of reconstituting and administering an injectable drug or medicine, distributed to practitioners in dry form, comprising:

receiving a drug or medicine in dry form;

selecting a reconstitution concentration for the drug or medicine;

reconstituting a desired number of units of the drug or medicine by adding diluent to the dry-form drug or medicine;

selecting a syringe that is pre-marked in correspondence to the selected reconstitution concentration;

after selecting the pre-marked syringe, drawing up a desired number of drug or medicine units using the selected syringe; and

administering a desired number of units according to the unit markings on the selected syringe.

2. The method of claim 1 , wherein the step of selecting a reconstitution concentration includes selecting the reconstitution concentration from a plurality of different standardized reconstitution concentrations.

3. The method of claim 2 , wherein the step of selecting a syringe includes selecting the syringe from a plurality of differently-marked syringes, wherein the markings on each of the plurality of syringes is representative of a particular standardized reconstitution concentration of the plurality of different standardized reconstitution concentrations.

4. The method of claim 3 , wherein the selected syringe is pre-marked with dosage units according to the selected reconstitution concentration, thereby directly indicating to a user the number of dosage units of the drug contained in the syringe.

5. The method of claim 3 , wherein the selected syringe is marked with an alphanumeric character indicating, to a user, the selected reconstitution concentration.

6. The method of claim 5 , wherein the alphanumeric character includes a number representative of the number of mL of diluent to be added to a predetermined quantity of the dry-form drug, thereby reconstituting the drug.

7. The method of claim 6 , wherein the predetermined quantity of the dry-form drug is 100 units.

8. The method of claim 6 , wherein the predetermined quantity of the dry-form drug is 300 units.

9. The method of claim 5 , wherein the alphanumeric character includes a letter.

10. The method of claim 5 , wherein the alphanumeric character includes a code representative of the selected reconstitution concentration.

11. The method of claim 3 , wherein the selected syringe is marked with a non-alphanumeric code that is representative of the selected reconstitution concentration.

12. The method of claim 11 , wherein the non-alphanumeric code includes one or more rings wherein the number of rings is indicative of the selected reconstitution concentration.

13. The method of claim 11 , wherein the non-alphanumeric code includes a color code wherein the color of one or more elements of the syringe are indicative of the selected reconstitution concentration.

14. The method of claim 3 , wherein the reconstituting step includes reconstituting the desired number of units of the drug or medicine by adding the diluent to the dry-form drug or medicine at the selected reconstitution concentration.

15. The method of claim 3 , wherein the selected syringe is marked with a manufacturing source identifier, thereby indirectly providing an indication of the unit measure, of a plurality of possible unit measures, with which the selected syringe is to be used.

16. The method of claim 3 , wherein the selected syringe is marked with an indication of the unit measure, of a plurality of possible unit measures, with which the selected syringe is to be used.

17. A method of distributing an injectable drug or medicine, provided in dry form, for reconstitution and administration, comprising:

packaging an injectable drug or medicine, in dry form, for distribution;

procuring a supply of syringes for use with a reconstituted form of the dry-form injectable drug or medicine, wherein each syringe is marked in such a way as to indicate, to a user, the concentration of the drug or medicine to be contained in the syringe when reconstituted and drawn thereinto, and wherein the supply of syringes include a multitude of each of a plurality of differently-marked syringes such that different syringes are to be used with different reconstitution concentrations; and

providing a quantity of the injectable drug or medicine to a practitioner in conjunction with one or more syringe together with printed information instructing a user with regard to the reconstitution of the drug or medicine in the concentration corresponding to the marking on the one or more syringe.

Continuity (2)
Provisional Application 61117815 · Nov 25, 2008
Related Publication 20100130961A1 · May 27, 2010